Heterologous vaccine regimens against COVID-19

被引：31

作者：

Duarte-Salles, Talita ^{[1
]}

Prieto-Alhambra, Daniel ^{[2
,3
]}

机构：

[1] Fundacio Inst Univ Recerca Atencio Primaria Salud, Barcelona 08007, Spain

[2] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

[3] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands

来源：

LANCET | 2021年 / 398卷 / 10295期

关键词：

D O I：

10.1016/S0140-6736(21)01442-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：94 / 95

页数：2

共 11 条

[1]

[Anonymous], 2021, COMUNICADO 17 SOC CI

[2] Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial [J].

Borobia, Alberto M. ;

Carcas, Antonio J. ;

Perez-Olmeda, Mayte ;

Castano, Luis ;

Jesus Bertran, Maria ;

Garcia-Perez, Javier ;

Campins, Magdalena ;

Portoles, Antonio ;

Gonzalez-Perez, Maria ;

Garcia Morales, Maria Teresa ;

Arana-Arri, Eunate ;

Aldea, Marta ;

Diez-Fuertes, Francisco ;

Fuentes, Inmaculada ;

Ascaso, Ana ;

Lora, David ;

Imaz-Ayo, Natale ;

Baron-Mira, Lourdes E. ;

Agusti, Antonia ;

Perez-Ingidua, Carla ;

Gomez de la Camara, Agustin ;

Ramon Arribas, Jose ;

Ochando, Jordi ;

Alcami, Jose ;

Belda-Iniesta, Cristobal ;

Frias, Jesus .

LANCET, 2021, 398 (10295) :121-130

[3]

European Centre for Disease Prevention EC Control., 2021, OV EU EEA COUNTR REC

[4]

European Medicines Agency, 2021, COVID 19 VACC UPD ON

[5]

European Medicines Agency, 2021, AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

[6] Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study [J].

Li, Xintong ;

Ostropolets, Anna ;

Makadia, Rupa ;

Shoaibi, Azza ;

Rao, Gowtham ;

Sena, Anthony G. ;

Martinez-Hernandez, Eugenia ;

Delmestri, Antonella ;

Verhamme, Katia ;

Rijnbeek, Peter R. ;

Duarte-Salles, Talita ;

Suchard, Marc A. ;

Ryan, Patrick B. ;

Hripcsak, George ;

Prieto-Alhambra, Daniel .

BMJ-BRITISH MEDICAL JOURNAL, 2021, 373

[7]

Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8

[8]

Medicines and Healthcare products Regulatory Agency, 2021, COR VACC WEEKL SUMM

[9]

Schmidt T., 2021, IMMUNOGENICITY REACT, V27, P1530, DOI [DOI 10.1101/2021.06.13.21258859, 10.1101/2021.06.13.21258859, 10.1038/s41591-021]

[10]

Shaw RH, 2021, LANCET, V397, P2043, DOI [10.1016/S0140-6736(21)01115-6, 10.1016/S0140-6736(21)01158-2]

← 1 2 →